Coverart for item
The Resource Clinical psychopharmacology for neurologists : a practical guide, George T. Grossberg, Laurence J. Kinsella, editors, (electronic resource)

Clinical psychopharmacology for neurologists : a practical guide, George T. Grossberg, Laurence J. Kinsella, editors, (electronic resource)

Label
Clinical psychopharmacology for neurologists : a practical guide
Title
Clinical psychopharmacology for neurologists
Title remainder
a practical guide
Statement of responsibility
George T. Grossberg, Laurence J. Kinsella, editors
Contributor
Subject
Language
eng
Dewey number
615.78
Index
no index present
Literary form
non fiction
Nature of contents
dictionaries
http://library.link/vocab/relatedWorkOrContributorName
  • Grossberg, George T.,
  • Kinsella, Laurence J.,
http://library.link/vocab/subjectName
  • Psychopharmacology
  • Dementia
  • Drug interactions
Label
Clinical psychopharmacology for neurologists : a practical guide, George T. Grossberg, Laurence J. Kinsella, editors, (electronic resource)
Instantiates
Publication
Contents
  • Intro; Foreword; Contents; Contributors; Chapter 1: Psychopharmacology for Neurologists; Clinical Vignette; Discussion; Scope of this Book; References; Chapter 2: General Principles of Psychopharmacology; Pharmacokinetics Vs. Pharmacodynamics; Pharmacokinetics; Pharmacodynamics; Drug Interactions; FDA Drug Approval; Off-Label Use; DEA Schedules of Drugs; Common Side Effects of Psychotropic Drugs and How to Manage Them; Neurotransmitter Systems; Specific Side Effects of Newer Psychotropic Drugs; Weight Gain; Sexual Dysfunction; Movement Disorders; Cardiovascular; Weight Loss; Hyponatremia
  • Cognitive ImpairmentSerum Glucose Alterations; Gastrointestinal Issues; Rash; What Is a Black Box Warning and Which Psychotropes Have One?; Drug Withdrawal/Discontinuation; Pregnant and Nursing Women: Special Considerations; Hepatic/Renal Insufficiency: Impact on Dosing; Renal Insufficiency; Hepatic Insufficiency; Laboratory Monitoring; Lithium Serum Levels; WBC for Clozapine and Carbamazepine; TCAs for Depression; Antipsychotics; Conclusion; References; Chapter 3: Special Considerations for the Elderly; Basic Principles of Geriatric Psycho-pharmacotherapy; Document Target Symptoms
  • Case StudyEnsure Close Collaboration Among Various Prescribers; Start One Medication at a Time; Start Low and Go Slow, But Go; Hepatic and Renal Considerations; Knowledge of Available Formulations; Knowledge of Drug-Drug Interactions; Assess Role of Gender, Lifestyle, Racial/Ethnic Differences in Drug Metabolism and Tolerance; Monitoring for Drug Response, Toxicity, and Interactions; Avoid Introducing a Drug to Treat the Side Effects of Another Drug; Case Study; Reducing Medication Burden; Periodic Drug Tapering and Discontinuation if Symptoms Are Well-Controlled; Patient and Family Education
  • Medication Cost/ReimbursementConclusion; References; Chapter 4: Antidepressants; Identifying Depression; Case Vignette: Part 1; Depression Screening; Subsyndromal Depression and Persistent Depressive Disorder; Case Vignette: Part 2; Subsyndromal Depression; Persistent Depressive Disorder (Dysthymia); Major Depressive Disorder; Case Vignette: Part 3; Diagnosing Major Depressive Disorder; Assessing Depression Severity; Completing the Assessment; Clinical Vignette: Part 3; Discussion; Prescribing an Antidepressant; Case Vignette: Part 4; Selecting an Antidepressant
  • Antidepressants for NeurologistsEvaluating and Adjusting Treatment; Case Vignette: Part 5; Evaluating Treatment Response; Continuing or Increasing the Antidepressant; Changing Antidepressants, if Not Effective; Goals and Duration of Treatment; Case Vignette: Part 6; Treat Residual Symptoms Fully; Duration of Treatment; Psychotherapy; Adverse Effects; Case Vignette: Part 7; Common Adverse Effects; Serious Adverse Effects; Other Adverse Effects; Discontinuation Syndrome; Neurological Illnesses; Epilepsy; Parkinson's Disease; Stroke; Multiple Sclerosis; Scales for Evaluating Treatment Response
Control code
on1036753982
Dimensions
unknown
Extent
1 online resource
Form of item
online
Isbn
9783319746043
Note
SpringerLink
Specific material designation
remote
System control number
(OCoLC)1036753982
Label
Clinical psychopharmacology for neurologists : a practical guide, George T. Grossberg, Laurence J. Kinsella, editors, (electronic resource)
Publication
Contents
  • Intro; Foreword; Contents; Contributors; Chapter 1: Psychopharmacology for Neurologists; Clinical Vignette; Discussion; Scope of this Book; References; Chapter 2: General Principles of Psychopharmacology; Pharmacokinetics Vs. Pharmacodynamics; Pharmacokinetics; Pharmacodynamics; Drug Interactions; FDA Drug Approval; Off-Label Use; DEA Schedules of Drugs; Common Side Effects of Psychotropic Drugs and How to Manage Them; Neurotransmitter Systems; Specific Side Effects of Newer Psychotropic Drugs; Weight Gain; Sexual Dysfunction; Movement Disorders; Cardiovascular; Weight Loss; Hyponatremia
  • Cognitive ImpairmentSerum Glucose Alterations; Gastrointestinal Issues; Rash; What Is a Black Box Warning and Which Psychotropes Have One?; Drug Withdrawal/Discontinuation; Pregnant and Nursing Women: Special Considerations; Hepatic/Renal Insufficiency: Impact on Dosing; Renal Insufficiency; Hepatic Insufficiency; Laboratory Monitoring; Lithium Serum Levels; WBC for Clozapine and Carbamazepine; TCAs for Depression; Antipsychotics; Conclusion; References; Chapter 3: Special Considerations for the Elderly; Basic Principles of Geriatric Psycho-pharmacotherapy; Document Target Symptoms
  • Case StudyEnsure Close Collaboration Among Various Prescribers; Start One Medication at a Time; Start Low and Go Slow, But Go; Hepatic and Renal Considerations; Knowledge of Available Formulations; Knowledge of Drug-Drug Interactions; Assess Role of Gender, Lifestyle, Racial/Ethnic Differences in Drug Metabolism and Tolerance; Monitoring for Drug Response, Toxicity, and Interactions; Avoid Introducing a Drug to Treat the Side Effects of Another Drug; Case Study; Reducing Medication Burden; Periodic Drug Tapering and Discontinuation if Symptoms Are Well-Controlled; Patient and Family Education
  • Medication Cost/ReimbursementConclusion; References; Chapter 4: Antidepressants; Identifying Depression; Case Vignette: Part 1; Depression Screening; Subsyndromal Depression and Persistent Depressive Disorder; Case Vignette: Part 2; Subsyndromal Depression; Persistent Depressive Disorder (Dysthymia); Major Depressive Disorder; Case Vignette: Part 3; Diagnosing Major Depressive Disorder; Assessing Depression Severity; Completing the Assessment; Clinical Vignette: Part 3; Discussion; Prescribing an Antidepressant; Case Vignette: Part 4; Selecting an Antidepressant
  • Antidepressants for NeurologistsEvaluating and Adjusting Treatment; Case Vignette: Part 5; Evaluating Treatment Response; Continuing or Increasing the Antidepressant; Changing Antidepressants, if Not Effective; Goals and Duration of Treatment; Case Vignette: Part 6; Treat Residual Symptoms Fully; Duration of Treatment; Psychotherapy; Adverse Effects; Case Vignette: Part 7; Common Adverse Effects; Serious Adverse Effects; Other Adverse Effects; Discontinuation Syndrome; Neurological Illnesses; Epilepsy; Parkinson's Disease; Stroke; Multiple Sclerosis; Scales for Evaluating Treatment Response
Control code
on1036753982
Dimensions
unknown
Extent
1 online resource
Form of item
online
Isbn
9783319746043
Note
SpringerLink
Specific material designation
remote
System control number
(OCoLC)1036753982

Library Locations

    • InternetBorrow it
      Albany, Auckland, 0632, NZ
Processing Feedback ...